Novartis AG
Tricyclic compounds useful to treat orthomyxovirus infections
Last updated:
Abstract:
The present invention provides a compound of Formula (I) including pharmaceutically acceptable salts thereof: ##STR00001## and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions to treat viral infections.
Status:
Grant
Type:
Utility
Filling date:
7 Mar 2017
Issue date:
8 Dec 2020